These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16108059)

  • 21. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
    Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
    Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.
    Zhao H; Lin W; Kumthip K; Cheng D; Fusco DN; Hofmann O; Jilg N; Tai AW; Goto K; Zhang L; Hide W; Jang JY; Peng LF; Chung RT
    J Hepatol; 2012 Feb; 56(2):326-33. PubMed ID: 21888876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
    Erickson AK; Seiwert S; Gale M
    Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.
    Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W
    Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection.
    Hopkins S; DiMassimo B; Rusnak P; Heuman D; Lalezari J; Sluder A; Scorneaux B; Mosier S; Kowalczyk P; Ribeill Y; Baugh J; Gallay P
    J Hepatol; 2012 Jul; 57(1):47-54. PubMed ID: 22425702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
    J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33.
    Wang S; Wu X; Pan T; Song W; Wang Y; Zhang F; Yuan Z
    J Gen Virol; 2012 Jan; 93(Pt 1):83-92. PubMed ID: 21957124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor.
    Hamamoto S; Fukuda R; Ishimura N; Rumi MA; Kazumori H; Uchida Y; Kadowaki Y; Ishihara S; Kinoshita Y
    J Lab Clin Med; 2003 Jan; 141(1):58-66. PubMed ID: 12518169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease.
    Hedegaard DL; Tully DC; Rowe IA; Reynolds GM; Bean DJ; Hu K; Davis C; Wilhelm A; Ogilvie CB; Power KA; Tarr AW; Kelly D; Allen TM; Balfe P; McKeating JA
    J Hepatol; 2017 Jan; 66(1):28-38. PubMed ID: 27531641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
    Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
    Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.
    Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F
    Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
    Israelow B; Narbus CM; Sourisseau M; Evans MJ
    Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.
    Yamauchi S; Takeuchi K; Chihara K; Honjoh C; Kato Y; Yoshiki H; Hotta H; Sada K
    Sci Rep; 2016 Dec; 6():38336. PubMed ID: 27929099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
    J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
    Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.